本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rapport Therapeutics, Inc.

23.16
-0.4300-1.82%
盘后:23.160.00000.00%19:30 EST
成交量:43.77万
成交额:1,019.83万
市值:13.73亿
市盈率:-7.29
高:23.83
开:23.23
低:23.00
收:23.59
52周最高:52.93
52周最低:22.06
股本:5,927.96万
流通股本:4,066.89万
量比:0.94
换手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-3.1753
每股收益(LYR):-2.8633
净资产收益率:-33.33%
总资产收益率:-21.97%
市净率:3.51
市盈率(LYR):-8.09

数据加载中...

2026/11/17

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/04

重要事件披露

Form 8-K - Current report
2026/10/30

重要事件披露

Form 8-K - Current report
2026/10/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/10/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/10/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/10/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/10/20

重要事件披露

Form 8-K - Current report
2026/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities